CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapine.

Dan J SiskindNadia FriendAnthony RussellJohn J McGrathCarmen LimSue PattersonDylan FlawsTerry StedmanVikas MoudgilSavio SardinhaShuichi SuetaniSteve KiselyKarl WinckelAndrea Baker

Published in: BMJ open (2018)

ACTRN12617001547336; Pre-results.

Keyphrases

weight gain
metabolic syndrome
body mass index
birth weight
randomized controlled trial
insulin resistance
weight loss
uric acid
physical activity
gestational age
cardiovascular risk factors